Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.

Zepbound® Medication

Discover Zepbound® by Eli Lilly, its benefits, studies, and potential side effects for informed choices.

Zepbound® (tirzepatide) is Eli Lilly’s FDA-approved brand-name, once-weekly injectable medication for chronic weight management in adults. Developed by Eli Lilly and approved in late 2023, Zepbound combines dual-incretin hormone action.

Zepbound is approved for adults with:

• A BMI of 30 or greater (obesity)

• Or a BMI of 27 or greater (overweight) with at least one weight-related medical condition such as type 2 diabetes, high blood pressure, or high cholesterol

Zepbound® for Weight Loss

How Zepbound® Works

Zepbound contains tirzepatide , a dual agonist of:

• GLP-1 (glucagon-like peptide-1)

• GIP (glucose-dependent insulinotropic polypeptide)

This “twin incretin” mechanism enhances the body’s ability to:

• Regulate blood sugar

• Control appetite

• Delay gastric emptying

• Boost fat metabolism

• Improve insulin sensitivity

The result is weight loss with additional metabolic benefits.

Efficacy and Results

In SURMOUNT-1 (New England Journal of Medicine, 2022), participants on the 15 mg dose lost an average of 20.9% of their starting body weight over 72 weeks, against 3.1% for placebo; among those who stayed on treatment throughout, the average was 22.5%.

Key outcomes from the SURMOUNT-1 study:

• 15 mg tirzepatide : Average of 52 lbs lost (~22.5% of body weight)

• Compared to placebo : ~5 lbs lost (~2.4%)

• More than 80% of users lost ≥15% of their body weight

Individual results will vary. This is not a guarantee of outcome.

Zepbound®

This is for exam and prescription only and we will assist you with getting your medications directly from the Eli Lilly Direct Pharmacy

Compounded Tirzepatide

Compounded tirzepatide is a breakthrough weight loss medication that contains the same drug substance used in GLP-1 receptor agonist therapy.

Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Made Ya Skinny is not affiliated with, endorsed by or sponsored by either company, and does not sell their products. Brand names appear here to identify the medicine being discussed.